E-Z-Em develops virtual colonoscopy agent

Article

E-Z-Em of Westbury, NY, announced this month that it has signedan agreement with Bowman Gray School of Medicine in Winston-Salem,NC, to develop an oral contrast agent for virtual colonoscopyprocedures under investigation at the hospital. The agent

E-Z-Em of Westbury, NY, announced this month that it has signedan agreement with Bowman Gray School of Medicine in Winston-Salem,NC, to develop an oral contrast agent for virtual colonoscopyprocedures under investigation at the hospital. The agent willminimize artifacts in 3-D images of the colon that can obscureor mimic polyps in virtual colonoscopy simulations. Virtual colonoscopyis being developed as an alternative to video-based colonoscopyscreening (SCAN 7/19/95).

In other news, E-Z-Em has introduced a new remote-controlledCT contrast injection system, PercuPump II. E-Z-Em used feedbackfrom radiologists and technologists in designing the system, whichuses a touch-screen remote control and features an optional thermalprinter to print a record of each patient's procedure.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.